Mainstream Germline Genetic Testing with Expanded Eligibility for Early Breast Cancer Patients in a Large Integrated Health System.

Autor: Shim V; Department of Surgery, Kaiser Permanente Oakland Medical Center, Oakland, CA, USA. veronica.shim@kp.org., Karlea A; Department of Genetics, Oakland, Kaiser Permanente, Oakland, USA., Brenman LM; Department of Genetics, Oakland, Kaiser Permanente, Oakland, USA., Gul J; Division of Research, Oakland, Kaiser Permanente, Oakland, USA., Hoodfar E; Department of Genetics, Sacramento, Kaiser Permanente, Sacramento, USA., Chan TD; Department of Surgery, Kaiser Permanente Oakland Medical Center, Oakland, CA, USA., Engeman PC; Department of Surgery, South Sacramento, Kaiser Permanente, Sacramento, USA., Sheldon VM; Department of Surgery, Central Valley, Kaiser Permanente, Modesto, USA., Thorne-Hadfield DM; Department of Radiology, San Rafael, Kaiser Permanente, San Rafael, USA., Odele P; Department of Surgery, San Rafael, Kaiser Permanente, San Rafael, USA., Vuong B; Department of Surgery, South Sacramento, Kaiser Permanente, Sacramento, USA., McEvoy J; Department of Surgery, Central Valley, Kaiser Permanente, Modesto, USA., Chang CK; Department of Surgery, Kaiser Permanente Oakland Medical Center, Oakland, CA, USA., Kotak D; Department of Medical Oncology, San Rafael, Kaiser Permanente, San Rafael, USA., Habel LA; Division of Research, Oakland, Kaiser Permanente, Oakland, USA.

Publikováno v: Annals of surgical oncology [Ann Surg Oncol] 2024 Sep 18. Date of Electronic Publication: 2024 Sep 18.